Patents by Inventor Jean-Charles Bensadoun

Jean-Charles Bensadoun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of IL-6/IL-6 chimera in Huntington's disease
    Patent number: 8329654
    Abstract: The invention relates to the use of an IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for the manufacture of a medicament for the treatment and/or prevention of Huntington's disease.
    Type: Grant
    Filed: March 4, 2010
    Date of Patent: December 11, 2012
    Assignee: Ares Trading S.A.
    Inventors: Nicole Deglon, Patrick Aebischer, Jean-Charles Bensadoun
  • USE OF IL-6/IL-6 CHIMERA IN HUNTINGTON'S DISEASE
    Publication number: 20100166703
    Abstract: The invention relates to the use of an IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for the manufacture of a medicament for the treatment and/or prevention of Huntington's disease.
    Type: Application
    Filed: March 4, 2010
    Publication date: July 1, 2010
    Applicant: ARES TRADING S.A.
    Inventors: NICOLE DEGLON, PATRICK AEBISCHER, JEAN-CHARLES BENSADOUN
  • USE OF IL-6/IL-6 CHIMERA IN HUNTINGTON'S DISEASE
    Publication number: 20070172454
    Abstract: The invention relates to the use of an IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for the manufacture of a medicament for the treatment and/or prevention of Huntington's disease.
    Type: Application
    Filed: January 11, 2007
    Publication date: July 26, 2007
    Applicant: ARES TRADING S.A.
    Inventors: Nicole Deglon, Patrick Aebischer, Jean-Charles Bensadoun
  • Use of il-6r/il-6 chimera in huntington's disease
    Publication number: 20040057928
    Abstract: The invention relates to the use of an IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for the manufacture of a medicament for the treatment and/or prevention of Huntington's disease.
    Type: Application
    Filed: September 16, 2003
    Publication date: March 25, 2004
    Inventors: Nicole Deglon, Patrick Aebischer, Jean-Charles Bensadoun